Safety Rates Drug Report: ATORVASTATIN Immune-mediated necrotising myopathy adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: ATORVASTATIN Injury: Immune-mediated necrotising myopathy Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 9 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
101441935	ATORVASTATIN	Immune-mediated necrotising myopathy	SANDOZ	81.00 YR	F	0	20160713	NO
102099533	ATORVASTATIN	Immune-mediated necrotising myopathy	RANBAXY	81.00 YR	F	0	20160917	NO
102343685	ATORVASTATIN	Immune-mediated necrotising myopathy	MERCK	81.00 YR	F	0	20160701	NO
102380943	ATORVASTATIN	Immune-mediated necrotising myopathy	TEVA	81.00 YR	F	0	20160718	NO
118935052	ATORVASTATIN	Immune-mediated necrotising myopathy	BRISTOL MYERS SQUIBB	18.00 YR	M	0	20160729	AU
124706282	Atorvastatin	Immune-mediated necrotising myopathy	RANBAXY	52.00 YR	M	0	20160930	US
124835512	Atorvastatin	Immune-mediated necrotising myopathy	RANBAXY	51.00 YR	F	0	20160802	IN
126587121	Atorvastatin	Immune-mediated necrotising myopathy	RANBAXY	56.00 YR	M	0	20160817	NZ
127240261	ATORVASTATIN	Immune-mediated necrotising myopathy	DR REDDYS	52.00 YR	M	0	20160908	COUNTRY NOT SPECIFIED

|< 1/2 << Previous Page Page 1

Total Records: 9 Number of Pages: 1

Execution Time: 0.16275787353516 seconds (ucode:5102937). Developed by: James D. Barger